目前,已有药物制造商生产出应用于临床的miRNA治疗试剂,尽管仍旧存在着较多问题,但随着miRNA研究的深入与成熟,相关药物开发和临床治疗也将提上日程。相信在不久的将来,随着miRNA分子诊断技术不断地评估完善及推广应用,医疗界会逐步建立起以分子诊断、仪器化疗、药品辅疗等多学科交叉诊疗相结合的科学医疗模式,miRNA在医疗应用领域定会取得突破性进展。参考文献
[1]Lee RC, Feinbaum RL, Ambros V.	TheC. elegansheterochronic gene lin-4, encodes small RNAs with antisense complementarity to lin-14.	Cell, 1993, 75	(5): 843–854.DOI:10.1016/0092-8674(93)90529-Y
[2]Dooley AL, Winslow MM, Chiang DY, et al.	Nuclear factor I/B is an oncogene in small cell lung cancer. Genes & Development, 2011, 25	(14): 1470–1475.
[3]Kosaka N, Iguchi H, Ochiya T, et al.	Circulating microRNA in body fluid:a new potential biomarker for cancer diagnosis and prognosis.	&#